- Home
- BCML vs TNXP Comparison
BCML vs TNXP Comparison
Compare BCML & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCML
- TNXP
- Stock Information
- Founded
- BCML 2004
- TNXP 2007
- Country
- BCML United States
- TNXP United States
- Employees
- BCML N/A
- TNXP N/A
- Industry
- BCML Major Banks
- TNXP Biotechnology: Pharmaceutical Preparations
- Sector
- BCML Finance
- TNXP Health Care
- Exchange
- BCML Nasdaq
- TNXP Nasdaq
- Market Cap
- BCML 294.2M
- TNXP 272.0M
- IPO Year
- BCML N/A
- TNXP N/A
- Fundamental
- Price
- BCML $27.65
- TNXP $45.03
- Analyst Decision
- BCML
- TNXP Strong Buy
- Analyst Count
- BCML 0
- TNXP 2
- Target Price
- BCML N/A
- TNXP $585.00
- AVG Volume (30 Days)
- BCML 29.7K
- TNXP 768.2K
- Earning Date
- BCML 07-21-2025
- TNXP 08-15-2025
- Dividend Yield
- BCML 2.89%
- TNXP N/A
- EPS Growth
- BCML N/A
- TNXP N/A
- EPS
- BCML 2.10
- TNXP N/A
- Revenue
- BCML $95,714,000.00
- TNXP $10,041,000.00
- Revenue This Year
- BCML $1.24
- TNXP $22.87
- Revenue Next Year
- BCML $6.52
- TNXP $711.66
- P/E Ratio
- BCML $13.17
- TNXP N/A
- Revenue Growth
- BCML N/A
- TNXP N/A
- 52 Week Low
- BCML $20.25
- TNXP $6.76
- 52 Week High
- BCML $30.13
- TNXP $130.00
- Technical
- Relative Strength Index (RSI)
- BCML 48.78
- TNXP 69.73
- Support Level
- BCML $27.40
- TNXP $38.87
- Resistance Level
- BCML $29.46
- TNXP $47.39
- Average True Range (ATR)
- BCML 0.72
- TNXP 2.82
- MACD
- BCML -0.06
- TNXP 0.80
- Stochastic Oscillator
- BCML 27.02
- TNXP 90.26
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.